MedVi vs PlushCare: Compare GLP-1 Programs & Pricing
Side-by-side MedVi and PlushCare: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.
MedVi and PlushCare are two established telehealth providers offering GLP-1–based weight‑management programs. This article compares MedVi vs PlushCare to help you identify which best fits your goals, budget, and preferred level of clinical support.
MedVi vs PlushCare: Quick Overview
| Provider | Semaglutide | Tirzepatide | Promo | Membership |
|---|---|---|---|---|
| MedVi | $179.00 | $279.00 | $120 off first month (Code: ) | — No |
| PlushCare | — No |
MedVi vs PlushCare: Medical Process & Accessibility
MedVi focuses on a streamlined telehealth intake, rapid clinician review, and same‑day prescription approval for eligible patients. After a brief health questionnaire, a board‑certified physician evaluates your medical history, confirms suitability for a GLP‑1 agent, and issues a prescription that is shipped to a U.S. pharmacy of your choice.
PlushCare follows a similar virtual workflow but incorporates scheduled follow‑up visits at weeks 2, 4, and 8 to assess tolerability and titrate dose. The platform also offers a dedicated care coordinator who can answer medication‑related questions throughout the treatment cycle. Both services comply with FDA regulations for telemedicine prescribing and require a valid U.S. prescription‑receiving address.
MedVi vs PlushCare: Pricing Comparison
MedVi lists its semaglutide program at $179.00 per month and tirzepatide at $279.00 per month. Because no other provider in this comparison publishes a lower price for the same medications, these figures are highlighted in bold for quick reference. In addition, MedVi offers a one‑time $120 discount on the first month of therapy (no promo code required).
PlushCare does not publicly disclose a starting price for semaglutide or tirzepatide on its website, so prospective patients should contact the provider directly for a customized quote. Neither platform charges a mandatory membership fee, and both state that enrollment is optional.
MedVi vs PlushCare: Clinical Oversight & Support
Both companies provide access to licensed clinicians who are authorized to prescribe GLP‑1 therapies. MedVi’s model is built around rapid approval, which can be advantageous for patients eager to start treatment quickly. PlushCare, on the other hand, emphasizes ongoing clinical oversight, with regular virtual visits that allow dose adjustments based on weight loss progress and side‑effect profile.
Book a Consultation with MedVi
MedVi vs PlushCare: Medication Quality & Safety
Each provider partners with FDA‑registered compounding pharmacies that adhere to Good Manufacturing Practice (GMP) standards. The compounded semaglutide and tirzepatide are chemically identical to their branded counterparts (e.g., Wegovy® and Mounjaro®) but are typically offered at a lower cost because they are not marketed under a brand name. All prescriptions are written by board‑certified physicians and are subject to the same safety monitoring required for any FDA‑approved medication.
MedVi vs PlushCare: Customer Experience
Patient reviews highlight MedVi’s affordability and the speed of its onboarding process as primary strengths. Users often mention that the platform’s straightforward questionnaire and quick prescription turnaround help them stay motivated early in their weight‑loss journey. PlushCare receives praise for its responsive care team, thorough follow‑up appointments, and the sense of a “personal health coach” guiding dose titration.
MedVi vs PlushCare: Final Verdict
If your priority is a low‑cost entry point with a fast, hassle‑free start, MedVi is the clear choice. The transparent pricing, $120 first‑month discount, and no‑membership requirement make it especially appealing for budget‑conscious consumers.
Conversely, if you value structured clinical follow‑up, a dedicated care coordinator, and the reassurance of scheduled dose‑adjustment visits, PlushCare may better match your preferences. Although the exact price is undisclosed, the added support can justify a higher expense for many patients.
Both platforms operate under U.S. telehealth regulations, require a licensed prescriber, and dispense medication from accredited pharmacies—ensuring that you receive safe, FDA‑compliant GLP‑1 therapy wherever you reside.
Join MedVi
Get Started with PlushCare
Disclaimer
This article is for informational purposes only and does not constitute medical advice. ExploreProviders may receive affiliate commissions at no cost to you. Always consult a licensed clinician before beginning any medical treatment.